Mesalamine - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > Mesalamine - Global Top Players Market Share and Ranking 2025

Mesalamine - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-09-18
Report Id: 2404947
Industry: Pharma & Healthcare
Report Page: 114
Chart: 113

PDF Download

Publication Date: 2025-09-18
Report Id: 2404947
Industry: Pharma & Healthcare
Report Page: 114
Chart: 113

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Mesalamine Definition
1.2 Global Mesalamine Market Size and Forecast
1.2.1 By Consumption Value, Global Mesalamine Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Mesalamine Market Size, 2020-2031
1.2.3 Global Mesalamine Average Selling Price (ASP), 2020-2031
1.3 China Mesalamine Market Size and Forecast
1.3.1 By Consumption Value, China Mesalamine Market Size, 2020-2031
1.3.2 By Sales Quantity, China Mesalamine Market Size, 2020-2031
1.3.3 China Mesalamine Average Selling Price (ASP), 2020-2031
1.4 Share of China Mesalamine Market with Respect to the Global Market
1.4.1 By Consumption Value, China Mesalamine Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Mesalamine Market Share in Global, 2020-2031
1.4.3 Mesalamine Market Size: China VS Global, 2020-2031
1.5 Mesalamine Market Dynamics
1.5.1 Mesalamine Market Drivers
1.5.2 Mesalamine Market Restraints
1.5.3 Mesalamine Industry Trends
1.5.4 Mesalamine Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Mesalamine, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Mesalamine, Global Market Share by Company, 2020-2025
2.3 Mesalamine Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Mesalamine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Mesalamine Concentration Ratio
2.6 Global Mesalamine Mergers & Acquisitions, Expansion Plans
2.7 Global Mesalamine Manufacturers Product Type
2.8 Head Office and Mesalamine Production Site of Key Manufacturer
2.9 Mesalamine Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Mesalamine, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Mesalamine, China Market Share by Company, 2020-2025
3.3 China Mesalamine Mesalamine Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Mesalamine Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Mesalamine Capacity by Region
4.3 Global Mesalamine Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Mesalamine Production by Region, 2020-2031
4.5 Global Mesalamine Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Mesalamine Industry Chain
5.2 Mesalamine Upstream Analysis
5.2.1 Mesalamine Core Raw Materials
5.2.2 Main Manufacturers of Mesalamine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Mesalamine Production Mode
5.6 Mesalamine Procurement Model
5.7 Mesalamine Industry Sales Model and Sales Channels
5.7.1 Mesalamine Sales Model
5.7.2 Mesalamine Typical Distributors

6 Sights by Type
6.1 Mesalamine Classification by Type
6.1.1 Purity ≥ 97%
6.1.2 Purity ≥ 98%
6.1.3 Purity ≥ 99%
6.2 by Type, Global Mesalamine Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Mesalamine Consumption Value, 2020-2031
6.4 by Type, Global Mesalamine Sales Quantity, 2020-2031
6.5 by Type, Global Mesalamine Average Selling Price (ASP), 2020-2031

7 Sights by Application
7.1 Mesalamine Segment by Application
7.1.1 Tablets
7.1.2 Capsules
7.1.3 Granule
7.1.4 Suppository
7.1.5 Enema
7.1.6 Others
7.2 by Application, Global Mesalamine Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Mesalamine Consumption Value, 2020-2031
7.4 by Application, Global Mesalamine Sales Quantity, 2020-2031
7.5 by Application, Global Mesalamine Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Mesalamine Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global Mesalamine Consumption Value, 2020-2031
8.3 By Region, Global Mesalamine Sales Quantity, 2020-2031
8.4 North America
8.4.1 North America Mesalamine Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Mesalamine Market Size Market Share
8.5 Europe
8.5.1 Europe Mesalamine Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Mesalamine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Mesalamine Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Mesalamine Market Size Market Share
8.7 South America
8.7.1 South America Mesalamine Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Mesalamine Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Mesalamine Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global Mesalamine Consumption Value, 2020-2031
9.3 By Country, Global Mesalamine Sales Quantity, 2020-2031
9.4 United States
9.4.1 United States Mesalamine Market Size, 2020-2031
9.4.2 by Type, United States Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.4.3 by Application, United States Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Mesalamine Market Size, 2020-2031
9.5.2 by Type, Europe Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.5.3 by Application, Europe Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.6 China
9.6.1 China Mesalamine Market Size, 2020-2031
9.6.2 by Type, China Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.6.3 by Application, China Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Mesalamine Market Size, 2020-2031
9.7.2 by Type, Japan Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.7.3 by Application, Japan Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Mesalamine Market Size, 2020-2031
9.8.2 by Type, South Korea Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.8.3 by Application, South Korea Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Mesalamine Market Size, 2020-2031
9.9.2 by Type, Southeast Asia Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.9.3 by Application, Southeast Asia Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.10 India
9.10.1 India Mesalamine Market Size, 2020-2031
9.10.2 by Type, India Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.10.3 by Application, India Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Mesalamine Market Size, 2020-2031
9.11.2 by Type, Middle East & Africa Mesalamine Sales Quantity Market Share, 2024 VS 2031
9.11.3 by Application, Middle East & Africa Mesalamine Sales Quantity Market Share, 2024 VS 2031

10 Manufacturers Profile
10.1 PharmaZell
10.1.1 PharmaZell Company Information, Head Office, Market Area, and Industry Position
10.1.2 PharmaZell Mesalamine Models, Specifications, and Application
10.1.3 PharmaZell Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.1.4 PharmaZell Company Profile and Main Business
10.1.5 PharmaZell Recent Developments
10.2 Syntese A/S
10.2.1 Syntese A/S Company Information, Head Office, Market Area, and Industry Position
10.2.2 Syntese A/S Mesalamine Models, Specifications, and Application
10.2.3 Syntese A/S Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Syntese A/S Company Profile and Main Business
10.2.5 Syntese A/S Recent Developments
10.3 Cambrex Corporation
10.3.1 Cambrex Corporation Company Information, Head Office, Market Area, and Industry Position
10.3.2 Cambrex Corporation Mesalamine Models, Specifications, and Application
10.3.3 Cambrex Corporation Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Cambrex Corporation Company Profile and Main Business
10.3.5 Cambrex Corporation Recent Developments
10.4 Divis Laboratories
10.4.1 Divis Laboratories Company Information, Head Office, Market Area, and Industry Position
10.4.2 Divis Laboratories Mesalamine Models, Specifications, and Application
10.4.3 Divis Laboratories Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Divis Laboratories Company Profile and Main Business
10.4.5 Divis Laboratories Recent Developments
10.5 Chemi SpA
10.5.1 Chemi SpA Company Information, Head Office, Market Area, and Industry Position
10.5.2 Chemi SpA Mesalamine Models, Specifications, and Application
10.5.3 Chemi SpA Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Chemi SpA Company Profile and Main Business
10.5.5 Chemi SpA Recent Developments
10.6 Ipca Laboratories
10.6.1 Ipca Laboratories Company Information, Head Office, Market Area, and Industry Position
10.6.2 Ipca Laboratories Mesalamine Models, Specifications, and Application
10.6.3 Ipca Laboratories Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Ipca Laboratories Company Profile and Main Business
10.6.5 Ipca Laboratories Recent Developments
10.7 Hangzhou Brother
10.7.1 Hangzhou Brother Company Information, Head Office, Market Area, and Industry Position
10.7.2 Hangzhou Brother Mesalamine Models, Specifications, and Application
10.7.3 Hangzhou Brother Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Hangzhou Brother Company Profile and Main Business
10.7.5 Hangzhou Brother Recent Developments
10.8 Lianyungang Fengheng Biopharm
10.8.1 Lianyungang Fengheng Biopharm Company Information, Head Office, Market Area, and Industry Position
10.8.2 Lianyungang Fengheng Biopharm Mesalamine Models, Specifications, and Application
10.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Lianyungang Fengheng Biopharm Company Profile and Main Business
10.8.5 Lianyungang Fengheng Biopharm Recent Developments
10.9 Lasa Loboratory
10.9.1 Lasa Loboratory Company Information, Head Office, Market Area, and Industry Position
10.9.2 Lasa Loboratory Mesalamine Models, Specifications, and Application
10.9.3 Lasa Loboratory Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Lasa Loboratory Company Profile and Main Business
10.9.5 Lasa Loboratory Recent Developments
10.10 Corden Pharma Bergamo
10.10.1 Corden Pharma Bergamo Company Information, Head Office, Market Area, and Industry Position
10.10.2 Corden Pharma Bergamo Mesalamine Models, Specifications, and Application
10.10.3 Corden Pharma Bergamo Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.10.4 Corden Pharma Bergamo Company Profile and Main Business
10.10.5 Corden Pharma Bergamo Recent Developments
10.11 Erregierre SpA
10.11.1 Erregierre SpA Company Information, Head Office, Market Area, and Industry Position
10.11.2 Erregierre SpA Mesalamine Models, Specifications, and Application
10.11.3 Erregierre SpA Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.11.4 Erregierre SpA Company Profile and Main Business
10.11.5 Erregierre SpA Recent Developments
10.12 CTX Lifescience
10.12.1 CTX Lifescience Company Information, Head Office, Market Area, and Industry Position
10.12.2 CTX Lifescience Mesalamine Models, Specifications, and Application
10.12.3 CTX Lifescience Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.12.4 CTX Lifescience Company Profile and Main Business
10.12.5 CTX Lifescience Recent Developments
10.13 Ishita Active Pharma Ingredients
10.13.1 Ishita Active Pharma Ingredients Company Information, Head Office, Market Area, and Industry Position
10.13.2 Ishita Active Pharma Ingredients Mesalamine Models, Specifications, and Application
10.13.3 Ishita Active Pharma Ingredients Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.13.4 Ishita Active Pharma Ingredients Company Profile and Main Business
10.13.5 Ishita Active Pharma Ingredients Recent Developments
10.14 YC Biotech (Jiangsu)
10.14.1 YC Biotech (Jiangsu) Company Information, Head Office, Market Area, and Industry Position
10.14.2 YC Biotech (Jiangsu) Mesalamine Models, Specifications, and Application
10.14.3 YC Biotech (Jiangsu) Mesalamine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.14.4 YC Biotech (Jiangsu) Company Profile and Main Business
10.14.5 YC Biotech (Jiangsu) Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Mesalamine should grow from US$ 202 million in 2024 to US$ 258 million by 2031, with a CAGR of 3.9% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Mesalamine

According to YH Research, the global market for Mesalamine should grow from US$ 202 million in 2024 to US$ 258 million by 2031, with a CAGR of 3.9% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Mesalamine also known as mesalazine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

In 2024, global Mesalamine sales reached approximately 5,417 tons, with an average global market price of around US$ 35.0 per kg.

The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.

With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.

Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

This report studies and analyses global Mesalamine status and future trends, helps the client to determine the Mesalamine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Mesalamine, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Mesalamine market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (Tons)
(2) Global Mesalamine sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Tons)
(3) China Mesalamine sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Tons)
(4) Global Mesalamine key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Mesalamine key producing regions, capacity, production, and year over year growth
(6) Mesalamine industry chains, upstream, midstream and downstream
Market segment by players, this report covers
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)

Market segment by Type, covers
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%

Market segment by Application, can be divided into
Tablets
Capsules
Granule
Suppository
Enema
Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Mesalamine product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Mesalamine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Mesalamine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Mesalamine, percent & CAGR, 2020-2031
Chapter 5: Mesalamine industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.